[P-HP] Hepatitis

[P-HP-21] Generation of human-rat chimeric anti-occludin monoclonal antibodies that strongly inhibit hepatitis C virus infection.

*Takeru Suzuki^1,2, Yoshimi Shimizu^1,3, Yoshitaka Shirasago¹, Kohei Yoneda⁴, Minoru Tada⁵, Akiko Ishii⁵, Kazuo Sugiyama⁶, Tetsuro Suzuki⁷, Takaji Wakita⁸, Kiyohito Yagi⁴, Masuo Kondoh⁴, Masayoshi Fukasawa¹ (1. Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, 2. Department of Biological Sciense and Technology, Tokyo University of Science, 3. Department of Pharmaceutical Sciences, Teikyo Heisei University, 4. Graduate School of Pharmaceutical Sciences, Osaka University, 5. Division of Biological Chemistry and Biologicals, National Institutes of Health Science, 6. Gyotoku General Hospital, 7. Department of Infectious Diseases, Hamamatsu University School of Medicine, 8. Department of Virology II, National Institute of Infectious Diseases)